Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Nephrology | Family Medicine
Disease Category: Kidney Cancer
Location: United States, WV

Clinical Trial Details

Overview

Research Study Summary

ECOG1808-A Randomized Phase II Trial of Sunitinib/Gemcitabine or Sunitinib in Advanced Renal Cell Carcinoma with Sarcomatoid Features

Purpose

Objective- To evaluate response rate of both the combination of sunitinib and gemcitabine and sunitinib alone in patients with advanced renal cell carcinoma with sarcomatoid features. To evaluate progression-free survival following treatment with both the combination of sunitinib and gemcitabine and sunitinib alone in this patient population.

To Learn more
Phase

2

Gender

Both Male and Female

Age

N/A

Overall Status

Recruiting

Facility Type

N/A

Contact

West Virginia University - Clinical Trials Research Unit
1637 Health Sciences South
Morgantown, WV 26506
Phone: 304-293-4944

View Map

CW ID: 170778

Date Last Changed: July 22, 2013


DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.